Pronova BioPharma appoints Per-Oluf Olsen as new CEO
Advertisement
Pronova BioPharma ASA announced that the board of directors has appointed Per-Oluf Olsen as chief executive officer to succeed Tomas Settevik, who has informed the board that he wishes to stand down from his position as CEO.
Per-Oluf Olsen, aged 52, will assume the role of CEO with effect from 17 November 2008. He joins Pronova BioPharma after 27 years with Pfizer Inc., where he gained extensive international experience in sales, marketing and management. Most recently, Mr. Olsen was regional executive director for Central and Eastern European region, inclusive regional office in Brussels. He was previously country manager for Pfizer in Italy, Norway and Denmark and has held a number of senior sales and marketing positions for the company in Norway and the USA.
Tomas Settevik will be proposed to be elected as a new board member at the annual general meeting in May 2009.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Mucosis Receives Financial Support from the Dutch Government for Its Flugem Program
Researchers find way to kill pathogen resistant to antibiotics
VTT has developed a rapid image analysis method to help diagnose Alzheimer's disease
A lab in your pocket
How brain areas communicate shapes human communication - The hearing regions in your brain form new alliances as you try to listen at the cocktail party